Literature DB >> 23123406

Prefrontal activity in Huntington's disease reflects cognitive and neuropsychiatric disturbances: the IMAGE-HD study.

M A Gray1, G F Egan, A Ando, A Churchyard, P Chua, J C Stout, N Georgiou-Karistianis.   

Abstract

Functional integrity of prefrontal cortico-striatal circuits underlying executive functioning may be compromised by basal ganglia degeneration during Huntington's disease (HD). This study investigated challenged inhibitory attentional control with a shifting response-set (SRS) task whilst assessing neural response via functional magnetic resonance imaging (fMRI) in 35 healthy controls, 35 matched pre-symptomatic (pre-HD) and 30 symptomatic (symp-HD) participants. A ≥70% performance accuracy threshold allowed confident identification of neural activity associated with SRS performance in a sub-set of 33 healthy controls, 32 pre-HD and 20 symp-HD participants. SRS activated dorsolateral prefrontal and dorsal anterior cingulate cortices, premotor, parietal, and basal ganglia regions and deactivated subgenual anterior cingulate cortex. Symp-HD participants showed greater prefrontal functional responses relative to controls and pre-HD, including larger activations and larger deactivations in response to cognitive challenge, consistent with compensatory neural recruitment. We then investigated associations between prefrontal BOLD responses, SRS performance accuracy and neuropsychiatric disturbance in all participants, including those below SRS performance accuracy threshold. We observed that reduced prefrontal responsivity in symp-HD was associated with reduced accuracy in SRS performance, and with increased neuropsychiatric disturbance within domains including executive dysfunction, pathological impulses, disinhibition, and depression. These findings demonstrate prefrontal response during inhibitory attentional control usefully characterises cognitive and neuropsychiatric status in symp-HD. The functional integrity of compensatory prefrontal responses may provide a useful marker for treatments which aim to sustain cognitive function and delay executive and neuropsychiatric disturbance.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23123406     DOI: 10.1016/j.expneurol.2012.10.020

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  26 in total

1.  Hyperactivity and cortical disinhibition in mice with restricted expression of mutant huntingtin to parvalbumin-positive cells.

Authors:  S E Dougherty; J J Hollimon; L J McMeekin; A S Bohannon; A B West; M Lesort; J J Hablitz; R M Cowell
Journal:  Neurobiol Dis       Date:  2013-10-11       Impact factor: 5.996

2.  Neuroanatomical Visualization of the Impaired Striatal Connectivity in Huntington's Disease Mouse Model.

Authors:  Dohee Kim; Jeha Jeon; Eunji Cheong; Dong Jin Kim; Hoon Ryu; Hyemyung Seo; Yun Kyung Kim
Journal:  Mol Neurobiol       Date:  2015-05-15       Impact factor: 5.590

3.  Disruption of response inhibition circuits in prodromal Huntington disease.

Authors:  Julia A Rao; Deborah L Harrington; Sally Durgerian; Christine Reece; Lyla Mourany; Katherine Koenig; Mark J Lowe; Vincent A Magnotta; Jeffrey D Long; Hans J Johnson; Jane S Paulsen; Stephen M Rao
Journal:  Cortex       Date:  2014-06-02       Impact factor: 4.027

Review 4.  Corticostriatal network dysfunction in Huntington's disease: Deficits in neural processing, glutamate transport, and ascorbate release.

Authors:  George V Rebec
Journal:  CNS Neurosci Ther       Date:  2018-02-21       Impact factor: 5.243

5.  Cdk5 Contributes to Huntington's Disease Learning and Memory Deficits via Modulation of Brain Region-Specific Substrates.

Authors:  Elena Alvarez-Periel; Mar Puigdellívol; Verónica Brito; Florian Plattner; James A Bibb; Jordi Alberch; Silvia Ginés
Journal:  Mol Neurobiol       Date:  2017-12-29       Impact factor: 5.590

6.  Longitudinal task-negative network analyses in preclinical Huntington's disease.

Authors:  Robert Christian Wolf; Fabio Sambataro; Nenad Vasic; Nadine Donata Wolf; Philipp Arthur Thomann; G Bernhard Landwehrmeyer; Michael Orth
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-09-27       Impact factor: 5.270

7.  Altered large-scale functional brain networks in neurological Wilson's disease.

Authors:  Rixing Jing; Yongsheng Han; Hewei Cheng; Yongzhu Han; Kai Wang; Daniel Weintraub; Yong Fan
Journal:  Brain Imaging Behav       Date:  2020-10       Impact factor: 3.978

8.  Functional magnetic resonance imaging of working memory in Huntington's disease: cross-sectional data from the IMAGE-HD study.

Authors:  Nellie Georgiou-Karistianis; Julie C Stout; Juan F Domínguez D; Sarah P Carron; Ayaka Ando; Andrew Churchyard; Phyllis Chua; India Bohanna; Alicia R Dymowski; Govinda Poudel; Gary F Egan
Journal:  Hum Brain Mapp       Date:  2013-08-02       Impact factor: 5.038

9.  Abnormal synchrony of resting state networks in premanifest and symptomatic Huntington disease: the IMAGE-HD study.

Authors:  Govinda R Poudel; Gary F Egan; Andrew Churchyard; Phyllis Chua; Julie C Stout; Nellie Georgiou-Karistianis
Journal:  J Psychiatry Neurosci       Date:  2014-03       Impact factor: 6.186

10.  Network topology and functional connectivity disturbances precede the onset of Huntington's disease.

Authors:  Deborah L Harrington; Mikail Rubinov; Sally Durgerian; Lyla Mourany; Christine Reece; Katherine Koenig; Ed Bullmore; Jeffrey D Long; Jane S Paulsen; Stephen M Rao
Journal:  Brain       Date:  2015-06-09       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.